New multifocal toric IOL approved

Alcon has received FDA approval for the AcrySof IQ ReSTOR +2.5 multifocal toric IOL with ActiveFocus, designed to correct astigmatism and presbyopia during cataract surgery.

Alcon says their new IOL is the only multifocal toric in which the central portion is completely dedicated to distance vision, unlike previous multifocal designs that compromised distance vision to achieve presbyopia correction.

The new lens is based on the AcrySof IQ toric IOL platform and is expected to be available in the US by mid-2017.

"The ActiveFocus toric IOL is the marriage of the design features of my two go-to IOLs for patients wanting outstanding distance vision and less dependence on glasses after cataract surgery," said Bret L. Fisher, MD, medical director of the Eye Center of North Florida. "By combining the unique optical properties of the ActiveFocus design with the unparalleled rotational stability of the AcrySof IQ toric platform, I can now offer a range of vision to more patients."